Nasdaq Composite stock performance (2026)
From ONEQ's filings and its holdings' prices. Not supplied or endorsed by Nasdaq.
Prices as of market close, Nov 17, 2026; membership from ONEQ's Aug 31, 2026 filing.
Loading this view…
It has not arrived yet. Try again or show the table.
Delayed prices refresh in ~ min · Upgrade to Pro for real-time prices →Upgrade to Pro →Upgrade →
Last close only · intraday with Pro →
Mutual funds · intraday prices aren't available
Columns & filters5 cols
60 a page
Nasdaq Composite stocks, ranked by YTD total, highest first: a table of category, price, 1D, YTD total and mkt cap / AUM.
| TickerCompany | ||||
|---|---|---|---|---|
| MRNAModerna | $206.80 | -3.93% | +601.3% | |
| SLSSELLAS Life Sciences Group | $19.15 | +156.36% | +408.0% | |
| ERASErasca | $13.89 | -8.07% | +273.4% | |
| TWSTTwist Bioscience | $112.00 | +6.63% | +253.1% | |
| KODKodiak Sciences | $96.80 | -3.90% | +246.2% | |
| TXG10x Genomics | $56.30 | +2.38% | +245.2% | |
| SNDKSandisk | $797.24 | -1.47% | +235.8% | |
| PLSEPulse Biosciences | $44.84 | -3.28% | +226.6% | |
| ABCLAbCellera Biologics | $11.03 | -0.81% | +222.5% | |
| ORKAOruka Therapeutics | $96.32 | -2.94% | +217.8% | |
| IBRXImmunityBio | $6.26 | +4.68% | +216.2% | |
| ELVNEnliven Therapeutics | $46.85 | -1.62% | +204.2% | |
| MXLMaxLinear | $51.42 | -1.06% | +195.0% | |
| SYRESpyre Therapeutics | $93.81 | -5.60% | +186.4% | |
| IOVAIovance Biotherapeutics | $7.53 | -0.26% | +175.8% | |
| ACHCAcadia Healthcare | $37.94 | -1.96% | +167.4% | |
| IRDMIridium Communications | $44.60 | -0.95% | +159.8% | |
| MUMicron Technology | $712.42 | -0.92% | +149.8% | |
| TNGXTango Therapeutics | $22.11 | -8.52% | +149.5% | |
| AEHRAehr Test Systems | $49.74 | -2.43% | +146.4% | |
| SEZLSezzle | $154.25 | -4.74% | +143.0% | |
| AMDAdvanced Micro Devices | $503.41 | -0.17% | +135.1% | |
| KNSAKiniksa Pharmaceuticals International | $95.11 | +0.93% | +130.6% | |
| STGWStagwell | $11.23 | -1.58% | +129.7% | |
| AMLXAmylyx Pharmaceuticals | $27.52 | -1.01% | +127.8% | |
| XNCRXencor | $34.50 | -2.54% | +125.3% | |
| CAKECheesecake Factory | $111.96 | +2.03% | +125.2% | |
| AXTIAXT | $36.42 | -5.30% | +122.8% | |
| DFTXDefinium Therapeutics | $29.38 | -2.59% | +119.4% | |
| DNTHDianthus Therapeutics | $86.98 | -2.87% | +111.1% | |
| TGTXTG Therapeutics | $62.71 | -0.08% | +110.4% | |
| RVMDRevolution Medicines | $162.69 | -2.50% | +104.3% | |
| OKTAOkta | $174.54 | -2.06% | +101.9% | |
| TRMDTORM | $33.73 | -6.42% | +101.7% | |
| CORTCorcept Therapeutics | $70.07 | +1.23% | +101.4% | |
| LFSTLifeStance Health Group | $14.17 | -2.14% | +101.3% | |
| CLOVClover Health Investments | $4.73 | -4.44% | +101.3% | |
| APAAPA | $46.88 | -0.89% | +97.1% | |
| LILAKLiberty Latin America | $9.90 | -0.50% | +95.3% | |
| RLAYRelay Therapeutics | $16.47 | -4.63% | +94.7% | |
| XMTRXometry | $114.95 | -5.88% | +93.3% | |
| ECPGEncore Capital Group | $104.75 | -1.40% | +92.7% | |
| NSITInsight Enterprises | $156.32 | +0.66% | +91.9% | |
| CGONCG Oncology | $78.94 | -6.89% | +90.1% | |
| VCTRVictory Capital Holdings | $117.88 | -1.76% | +90.1% | |
| CRWDCrowdStrike Holdings | $219.58 | -1.63% | +87.4% | |
| BTSGBrightSpring Health Services | $69.83 | -2.16% | +86.5% | |
| CROXCrocs | $158.79 | -0.76% | +85.7% | |
| VSATViaSat | $63.94 | +0.06% | +85.5% | |
| STXSeagate Technology Holdings | $504.40 | +1.08% | +83.8% | |
| ICHRIchor Holdings | $33.64 | -0.03% | +82.5% | |
| RPRXRoyalty Pharma | $68.68 | +0.23% | +80.8% | |
| ARCBArcBest | $132.52 | -2.25% | +79.3% | |
| ROIVRoivant Sciences | $38.71 | +0.26% | +78.4% | |
| ADPTAdaptive Biotechnologies | $28.49 | +2.22% | +75.4% | |
| MRVLMarvell Technology | $148.74 | +2.33% | +75.3% | |
| MRXMarex Group | $66.40 | -5.95% | +75.1% | |
| MGNIMagnite | $28.41 | -1.32% | +75.0% | |
| TXNTexas Instruments | $295.86 | +0.56% | +74.2% | |
| SGRYSurgery Partners | $26.85 | +0.22% | +73.8% |
60 a page
Total return: dividends reinvested. During the session it counts a dividend going ex today once it is on record; the nightly update corrects anything it missed. 21 of 845 Nasdaq Composite stocks have no YTD figure and are left out. Not investment advice.
Methodology#
The list is ONEQ's latest SEC Form N-PORT filing. Weights are ChartRow's estimates, not ONEQ's actual weights: they start from the holdings ONEQ disclosed to the SEC on Form N-PORT, which we roll forward using each member's subsequent price change, estimate any post-filing additions from market cap, and combine multiple share classes of the same company into one row (the table's Est. weight column). Total return is measured over adjusted closes, which treat dividends as reinvested, and price return is the price change alone; today is the regular session's price move. In session every period adds the live price move and any dividend going ex that day that is already on record, and the nightly update corrects anything missed. See the full constituents and weights, or the YTD return.
FAQ#
- What is the best-performing Nasdaq Composite stock in 2026?
- Moderna Inc. (MRNA) is the best-performing Nasdaq Composite stock of 2026 so far, with a +601.3% year-to-date total return.
- What is the worst-performing Nasdaq Composite stock in 2026?
- Eos Energy Enterprises Inc. (EOSE) is the worst-performing Nasdaq Composite stock of 2026 so far, with a -87.0% year-to-date total return.
- Which Nasdaq Composite stock has the highest 10-year return?
- Applied Digital Corporation (APLD) has the highest 10-year total return of today's Nasdaq Composite members, +72823.1% in total, +93.3% a year compounded (CAGR). 95 of 845 members listed within the last ten years and are left out of that ranking.
- Does this ranking include dividends?
- Yes. Every period from 5 days through 30 years is a total return, with dividends reinvested. During the session it counts a dividend going ex that day once it is on record, and the nightly update corrects anything it missed. The 1-day column is the price move, the way quote screens report it. A period of whole years also shows the compounded annual rate (CAGR).
- Where does the Nasdaq Composite company list come from?
- The list is ONEQ's latest SEC Form N-PORT filing. Weights are rolled forward with each company's price move.
More on Nasdaq Composite
- Companies & weights1010
- Sector weights51.0%
- Return calculator$1,604
- Dividend yield0.62%
- Buyback yield1.13%
- Shareholder yield1.68%
- Earnings$1.55T
- Returns by year+5.4%
Sources
- ONEQ's SEC filings: The fund's holdings as it reports them on Form N-PORT, public on SEC EDGAR; ChartRow rolls the weights forward by price.
- ONEQ's holdings' prices: Each company's market prices and dividends, licensed from Twelve Data.
ChartRow is not affiliated with, sponsored by, or endorsed by S&P Dow Jones Indices LLC, S&P Global, Nasdaq, Inc., FTSE Russell, MSCI Inc., Robert Shiller, RSBB-I, LLC, or Yale University. "S&P 500®" and "S&P®" are registered trademarks of Standard & Poor's Financial Services LLC and "Dow Jones®" of Dow Jones Trademark Holdings LLC, both licensed to S&P Dow Jones Indices LLC; "Nasdaq-100®" is a registered trademark of Nasdaq, Inc.; "CAPE®" is a registered trademark of RSBB-I, LLC; all other index names are trademarks of their owners. They are used here only to identify those indexes and the funds that seek to track them. ChartRow receives no data from, and holds no licence from, any index provider: the holdings and weights shown start from the tracking fund's own holdings as reported in its public SEC filings, updated where noted for publicly announced index changes since the latest filing and rolled forward by ChartRow from daily prices, with any name added since the filing estimated from market cap; returns are the fund's own market prices; long-run S&P 500 history comes from public research datasets, Robert Shiller's and Aswath Damodaran's, credited where used. These figures are ChartRow's own estimates and computations from public filings, prices and research records, provided for information only and without warranty of accuracy; they are not the fund's or any index provider's official figures and may differ from them.
